Trial Details
TERMINATEDBasic Information
| Clinical ID | c1016 |
|---|---|
| Identifier | NCT05688852 |
| Trial Title | VTX958 for the Treatment of Moderately to Severely Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: VTX958|DRUG: VTX958|DRUG: VTX958 Placebo |
Participant Information
| Sponsor | Ventyx Biosciences, Inc |
|---|---|
| City | Garden Grove |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2023-01-25 |
|---|---|
| Primary Completion Date | 2024-06-27 |
| Completion Date | 2024-12-20 |